Skip to content
MS
Sign in
Single-pathway Pathway metabolite unreviewed

ApoA-I

0
Pathways
0
Categories
0
As substrate
0
As product
What can this become? Show on map

Reactions involving ApoA-I

Every recorded step where this molecule takes part

All 1 Consumed 1 Produced 0

Showing all 1 reactions.

Recent literature

Refresh

Europe PMC · fetched just now · sorted by publication date

  1. 1
    Tumor microenvironment-responsive conformational activation of apoA-I mimetic peptides for targeted cancer therapy.

    Rui M, Fang L, Jia M, Liang W, Li Y, Ruan Y, Feng C. · 2025-12-17

    open access unreviewed
  2. 2
    Early atherogenesis: In search of etiology.

    Brown PA. · 2026-05-07

    open access unreviewed
  3. 3
    Lycium barbarum glycopeptide alleviates diabetic retinopathy and hepatic lipid disorder via modulation of the LXR-α/ABC transporter axis.

    Wang Y, Zhang Y, Che X, Xu X, Wang K, Shi Y, Wang M, Wang F, Liu S, Jia Z, Luo Y, Sun X. · 2026-05-14

    unreviewed
  4. 4
    Clinical applications of artificial intelligence-driven nitric oxide: a bibliometric and scientific mapping analysis.

    Liu Z, Abulaiti A, Zhao Y, Zang J, Li G, Shu L, Wahafu P, Yakufu M. · 2026-01-06

    open access unreviewed
  5. 5
    COPI Coatomer Regulates Several Steps of HDL Metabolism.

    Panteloglou G, Zanoni P, Law CS, Woods B, Othman A, Yalcinkaya M, Norrelykke SF, Rzepiela AJ, Stoma S, Steble… · 2026-08-13

    unreviewed
  6. 6
    HDL-associated proteins affecting CVD and systemic inflammation.

    Delk SC, Reddy ST. · 2026-08-13

    unreviewed
  7. 7
    Efficacy of phytosterols for reduction of cardiometabolic risk factors: An umbrella review of systematic reviews and meta-analyses and updated dose-response meta-analyses of randomized trials.

    Zurbau A, Haintz L, Chen V, Glenn AJ, Kavanagh ME, Oguntala JO, Blanco Mejia S, Khan TA, Leiter LA, Kendall C… · 2026-05-26

    unreviewed
  8. 8
    Edaravone attenuates carbonyl-stress-driven ApoA-I carboxymethylation and macrophage cholesterol-handling dysfunction in diabetic atherosclerosis.

    Ma HC, Xu YX, Zhang ZR, Zhang LF, Zhou XF, Luo HY, Xiong NQ, Song KC, Pu LJ. · 2026-07-30

    unreviewed
  9. 9
    Effect of the hepatokine Tsukushi on HDL and reverse cholesterol transport.

    Lam S, Wong Y, Wing-Ming Shiu S, Lee CH, Choon-Beng Tan K. · 2026-07-20

    unreviewed
  10. 10
    No beneficial effect of resveratrol supplementation on plasma apolipoprotein B and apolipoprotein A-I levels: a systematic review and meta-analysis of randomized controlled trials.

    Simental-Mendía LE, Arce-Quiñones M, Sahebkar A. · 2026-07-11

    unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.